表紙
市場調査レポート

個別化医療における診断:フローサイトメトリー、敗血症免疫、ルーチン凝固、精神疾患、分子血液タイピングおよびその他の検査

Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)

発行 Renub Research 商品コード 166524
出版日 ページ情報 英文 173 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
個別化医療における診断:フローサイトメトリー、敗血症免疫、ルーチン凝固、精神疾患、分子血液タイピングおよびその他の検査 Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)
出版日: 2013年06月13日 ページ情報: 英文 173 Pages
概要

世界の個別化医療市場は2018年までに300億米ドルに達すると予測されています。糖尿病管理検査およびがん治療検査が主要市場となっています。

当レポートでは、世界の個別化医療市場について分析し、セグメント別の市場動向と将来予測、様々な技術開発動向などをまとめ、参入企業のプロファイルを織り交ぜ、概略以下の構成でお届けします。

第1章 エグゼクティブサマリー

第2章 世界の個別化医療における診断市場・予測

  • 技術別
  • 疾患別

第3章 世界の個別化医療における診断市場シェアセグメント

  • 技術別
  • 疾患別

第4章 個別化医療における診断市場・予測:技術別

  • 薬理遺伝学
  • 薬理ゲノム
  • SNP遺伝子型
  • ファーマコプロテオミクス
  • バイオチップ
  • ポイントオブケア
  • 分子診断
  • 遺伝子スクリーニング

第5章 個別化医療における診断市場・予測:地域別

  • 北米
  • 西欧(EU5ヶ国)

第6章 個別化医療における診断市場のシェア・予測:疾患別

  • 心血管管理検査市場のシェア・予測
  • 糖尿病検査市場のシェア・予測
  • 凝固検査市場のシェア・予測
  • がん治療検査市場のシェア・予測
  • 感染症検査市場のシェア・予測

第7章 個別化医療における診断市場・予測:疾患別

  • 心血管管理検査市場・予測
  • 心血管管理検査市場・予測:セグメント別
  • 糖尿病検査市場・予測
  • 糖尿病検査市場・予測:セグメント別
  • 凝固検査市場・予測
  • 凝固検査市場・予測:セグメント別
  • がん治療検査市場・予測
  • がん治療検査市場・予測:セグメント別
  • 感染症検査市場・予測
  • 感染症検査市場・予測:セグメント別
  • 微生物特定/抗生物質感受性検査(ID/AST)市場・予測
  • 精神疾患検査市場・予測
  • 移植用組織タイピング(HLA)試験市場・予測
  • 分子血液タイピング市場・予測

第8章 個別化医療の治験状況

  • 血液癌患者における個別化医療向けバイオマーカー研究
  • 免疫表現型不一致の遺伝子&環境因子:個別化医療に向けた筋道の構築
  • 治療開始時に遺伝子検査を受けた成人のワルファリン有害事象の減少
  • 病的肥満向け個別化医療の遺伝子分析
  • 抗鬱剤ガイダンス&教育向け薬理ゲノム
  • I-SPY 2試験(画像&分子分析による治療反応を予測する一連の研究の調査)
  • ヒトの高血圧向けRAAS阻害薬研究における遺伝子メカニズム
  • 薬物代謝・輸送の機能解析向け非盲検試験
  • 非小細胞肺癌における個別化療法
  • 小児ぜんそく向け個別化医療のパイロット研究

第9章 個別化医療市場における主要投資家

第10章 個別化医療診断市場における成長の主要促進因子(機会)

  • 個別化医療診断市場を形成する政府機関
  • 個別化医療において単独ではなく、協力して利益を得る組織
  • ひとつの薬が全てに効くという大ヒットモデルは圧力を受ける

第11章 個別化医療診断市場における課題

  • 医療費償還政策・規制の枠組み
  • 規制の枠組み
  • 医療費支払い社は個別化医療のコストが維持できないことを心配

第12章 企業分析

  • HistoRx
  • A&G Pharmaceutical, Inc
  • 20/20 GeneSystems
  • Tethys Bioscience
  • Genomas, Inc.

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Personalized Medicine is often defined as “the right treatment for the right person at the right time.” Personalized medicine is becoming the place to be in clinical diagnostics as well and slowly becoming the reality of future in the diagnostics industry

By Technology Segment - Personalized Medicine diagnostics market is expected to grow with a double digit CAGR for the period of 2013 to 2018. It is expected that personalized medicine diagnostics market by technology is going to double by 2018 from its current market size in 2012. In this segment, Point of Care Testing and Molecular Diagnostics segments control the #1 and #2 positions in 2012.

By Diseases Segment - Personalized Medicine diagnostics market is expected to be more than US$ 30 Billion by 2018. Diabetes management test and Cancer management test are the leading market in this segment.

Renub Research report entitled “Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)” report provides a comprehensive analysis of the emerging personalized medicine diagnostic market segments, including their dynamics, size, market share, key investors, clinical trials statement, technological trends, company analysis and a realistic future potential for personalized medicine in clinical testing. The report also entails major drivers and challenges of personalized medicine diagnostic market.

This 173 page report contains 94 Figures and 16 Tables studies the Personalized Medicine Diagnostics Market.

This report contains 12 chapters:

  • Chapter 1 is Executive Summary
  • Chapter 2 contains worldwide personalized medicine diagnostic market & forecast (2011 - 2018). The market includes technological & disease-wise personalized medicine diagnostics market
  • Chapter 3 contains worldwide personalized medicine diagnostic market share segment. Segment include Technology, Disease-Wise
  • Chapter 4 contains segment-wise technological personalized diagnostic market & forecast (2010 - 2018)
  • Chapter 5 contains geographical segment-wise personalized diagnostic market & forecast (2011 - 2018)
  • Chapter 6 contains disease-wise personalized diagnostic market share & forecast (2011 - 2018)
  • Chapter 7 contains disease-wise personalized diagnostic market & forecast (2011 - 2018)
  • Chapter 8 and 9 contains clinical trial statement and key investors in Personalized Diagnostics Medicine Market
  • Chapter 10 and 11 contains growth Drivers & Challenges for Personalized Medicine
  • Chapter 12 contains company analysis of Personalized Medicine

Companies analyzed in this report are:

  • HistoRx
  • A&G Pharmaceuticals Inc
  • 20/20 GeneSystems
  • Tethys Bioscience
  • Genomas Inc

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table of Contents

1. Executive Summary

2. Worldwide Personalized Medicine Diagnostic Market & Forecast

  • 2.1. By Technology - Worldwide Personalized Medicine Diagnostic Market & Forecast
  • 2.2. By Diseases - Worldwide Personalized Medicine Diagnostic Market & Forecast

3. Worldwide - Personalized Medicine Diagnostic Market Share Segment

  • 3.1. By Technology - Worldwide Personalized Medicine Diagnostic Market Share & Forecast
  • 3.2. By Disease - Worldwide Personalized Medicine Diagnostic Market Share & Forecast

4. By Technology - Personalized Medicine Diagnostic Market & Forecast

  • 4.1. Worldwide - Pharmacogenetics Market & Forecast
  • 4.2. Worldwide - Pharmacogenomics Market & Forecast
  • 4.3. Worldwide - SNP Genotyping Market & Forecast
  • 4.4. Worldwide - Pharmacoproteomics Market & Forecast
  • 4.5. Worldwide - Biochips Market & Forecast
  • 4.6. Worldwide - Point of Care Test Market & Forecast
  • 4.7. Worldwide - Molecular Diagnostics Market & Forecast
  • 4.8. Worldwide - Genetic Screening Market & Forecast

5. By Geographical Segmentation - Personalized Medicine Diagnostic Market & Forecast

  • 5.1. North America - Personalized Medicine Diagnostic Market & Forecast
  • 5.2. Western Europe (EU5) - Personalized Medicine Diagnostic Market & Forecast

6. By Disease - Personalized Medicine Diagnostic Market Share & Forecast

  • 6.1. Worldwide - Cardiovascular Management Test Market Share & Forecast
  • 6.2. Worldwide - Diabetes Management Test Market Share & Forecast
  • 6.3. Worldwide - Coagulation Test Market Share & Forecast
  • 6.4. Worldwide - Cancer Management Test Market Share & Forecast
  • 6.5. Worldwide - Infectious Diseases Test Market Share & Forecast

7. By Disease - Personalized Medicine Diagnostic Market & Forecast

  • 7.1. Worldwide - Cardiovascular Management Test Market & Forecast
  • 7.2. Worldwide - Cardiovascular Management Test Market & Forecast (By Segment)
    • 7.2.1. Cardiac Marker Immunoassays Market & Forecast
    • 7.2.2. Cardiac Risk Markers Market & Forecast
    • 7.2.3. Cardiac Markers Molecular Test Market & Forecast
  • 7.3. Worldwide - Diabetes Management Test Market & Forecast
  • 7.4. Worldwide - Diabetes Management Test Market & Forecast (By Segment)
    • 7.4.1. Blood Glucose Monitoring Market & Forecast
    • 7.4.2. Hemoglobin A1C (HbA1c) Test Market & Forecast
  • 7.5. Worldwide - Coagulation Test Market & Forecast
  • 7.6. Worldwide - Coagulation Test Market & Forecast (By Segment)
    • 7.6.1. Routine Coagulation Test Market & Forecast
    • 7.6.2. Molecular Coagulation Test Market & Forecast
  • 7.7. Worldwide - Cancer Management Test Market & Forecast
  • 7.8. Worldwide - Cancer Management Test Market & Forecast (By Segment)
    • 7.8.1. Pharmacodiagnostic Histology Test Market & Forecast
    • 7.8.2. Flow Cytometry Market & Forecast
    • 7.8.3. Tumor Markers Market & Forecast
    • 7.8.4. Human Papillomavirus (HPV) Test Market & Forecast
    • 7.8.5. Molecular Assays Market & Forecast
    • 7.8.6. Circulating Tumor Cells Market & Forecast
  • 7.9. Worldwide - Infectious Diseases Test Market & Forecast
  • 7.10. Worldwide - Infectious Diseases Test Market (By Segment)
    • 7.10.1. Human Immunodeficiency Virus (HIV) CD4 Count Market & Forecast
    • 7.10.2. Human Immunodeficiency Virus (HIV) Viral Load Test Market & Forecast
    • 7.10.3. Hepatitis C (HCV) Viral Load Test Market & Forecast
    • 7.10.4. Hepatitis B (HBV) Viral Load Test Market & Forecast
    • 7.10.5. Hospital Acquired Infections (HAI) Molecular Test Market & Forecast
    • 7.10.6. Sepsis Immunos Test Market & Forecast
    • 7.10.7. Multi Drug Resistant Tuberculosis (MDR-TB) Test Market & Forecast
  • 7.11. Worldwide - Microbiology Identification/ Antibiotic Sensitivity Test (ID/AST) Market & Forecast
  • 7.12. Worldwide - Psychiatric Disorders Test Market & Forecast
  • 7.13. Worldwide - Transplant Tissue Typing (HLA) Test Market & Forecast
  • 7.14. Worldwide - Molecular Blood Typing Market & Forecast

8. Personalized Medicine Clinical Trial Statement

  • 8.1. Biomarker Research for Personalized Medicine in Blood Cancer Patient
  • 8.2. Genetic & Environmental Determinants of Immune Phenotype Variance: Establishing a Path towards Personalized Medicine
  • 8.3. Warfarin Adverse Event Reduction for Adults Receiving Genetic Testing at Therapy Initiation (WARFARIN)
  • 8.4. Genetic Analysis for Personalized Medicine for Morbid Obesity
  • 8.5. Pharmacogenomics for Antidepressant Guidance & Education
  • 8.6. I-SPY 2 Trial (Investigation of Serial Studies to Predict your Therapeutic Response with Imaging & Molecular Analysis)
  • 8.7. Genetic Mechanisms in Human Hypertension RAAS Inhibition Study
  • 8.8. Open Label Study for the Functional Characterization of Drug Metabolism and Transport
  • 8.9. Personalized Therapy in Non-Small Cell Lung Cancer
  • 8.10. A Pilot Study of Personalized Medicine for Pediatric Asthma

9. Key Investors in Personalized Medicine Market

10. Key Drivers (Opportunities) of Growth in Personalized Medicine Diagnostic Market

  • 10.1. Government Agencies Shaping Personalized Medicine Diagnostic Market
  • 10.2. Organizations will Profit Together, Not Alone in the Personalized Medicine
  • 10.3. The Blockbuster Model of One Drug Fits all is under Pressure

11. Challenges in Personalized Medicine Diagnostic Market

  • 11.1. Reimbursement Policy & Regulatory Framework
  • 11.2. Regulatory Framework
  • 11.3. Payers Worry That Cost of Personalized Medicine Could Be Unsustainable

12. Company Analysis

  • 12.1. HistoRx
    • 12.1.1. Focus/Market Served
    • 12.1.2. Outlook/ Strategy for Success
    • 12.1.3. Products
  • 12.2. A&G Pharmaceutical, Inc
    • 12.2.1. Focus/Market Served
    • 12.2.2. Outlook/Strategy for Success
    • 12.2.3. Products
  • 12.3. 20/20 GeneSystems
    • 12.3.1. Focus/Market Served
    • 12.3.2. Outlook/Strategy for Success
    • 12.3.3. Products
  • 12.4. Tethys Bioscience
    • 12.4.1. Focus/Market Served
    • 12.4.2. Outlook/Strategy for Success
    • 12.4.3. Products
  • 12.5. Genomas, Inc.
    • 12.5.1. Focus/Market Served
    • 12.5.2. Products

List of Figures:

  • Figure 2-1: Worldwide - By Technology Personalized Medicine Diagnostic Market (Million US$), 2010 - 2012
  • Figure 2-2: Worldwide - Forecast for By Technology Personalized Medicine Diagnostic Market (Million US$), 2013 - 2018
  • Figure 2-3: Worldwide - By Diseases Personalized Medicine Diagnostic Market (Million US$), 2011 - 2012
  • Figure 2-4: Worldwide - Forecast for By Diseases Personalized Medicine Diagnostic Market (Million US$), 2013 - 2018
  • Figure 3-1: Worldwide - By Technology Personalized Medicine Diagnostic Market Share (Percent), 2010 - 2012
  • Figure 3-2: Worldwide - Forecast for By Technology Personalized Medicine Diagnostic Market Share (Percent), 2013 - 2018
  • Figure 4-1: Worldwide - Pharmacogenetics Market (Million US$), 2010 - 2012
  • Figure 4-2: Worldwide - Forecast for Pharmacogenetics Market (Million US$), 2013 - 2018
  • Figure 4-3: Worldwide - Pharmacogenomics Market (Million US$), 2010 - 2012
  • Figure 4-4: Worldwide - Forecast for Pharmacogenomics Market (Million US$), 2013 - 2018
  • Figure 4-5: Worldwide - SNP Genotyping Market (Million US$), 2010 - 2012
  • Figure 4-6: Worldwide - Forecast for SNP Genotyping Market (Million US$), 2013 - 2018
  • Figure 4-7: Worldwide - Pharmacoproteomics Market (Million US$), 2010 - 2012
  • Figure 4-8: Worldwide - Forecast for Pharmacoproteomics Market (Million US$), 2013 - 2018
  • Figure 4-9: Worldwide - Biochips Market (Million US$), 2010 - 2012
  • Figure 4-10: Worldwide - Forecast for Biochips Market (Million US$), 2013 - 2018
  • Figure 4-11: Worldwide - Point of Care Testing Market (Million US$), 2009 - 2012
  • Figure 4-12: Worldwide - Forecast for Point of Care Testing Market (Million US$), 2013 - 2018
  • Figure 4-13: Worldwide - Molecular Diagnostics Market (Million US$), 2010 - 2012
  • Figure 4-14: Worldwide - Forecast for Molecular Diagnostics Market (Million US$), 2013 - 2018
  • Figure 4-15: Worldwide - Genetic Screening Market (Million US$), 2010 - 2012
  • Figure 4-16: Worldwide - Forecast for Genetic Screening Market (Million US$), 2013 - 2018
  • Figure 5-1: North America - Personalized Medicine Diagnostic Market (Million US$), 2011 - 2012
  • Figure 5-2: North America - Forecast for Personalized Medicine Diagnostic Market (Million US$), 2013 - 2018
  • Figure 5-3: Western Europe (EU-5) - Personalized Medicine Diagnostic Market (Million US$), 2011 - 2012
  • Figure 5-4: Western Europe (EU-5) - Forecast for Personalized Medicine Diagnostic Market (Million US$), 2013 - 2018
  • Figure 6-1: Worldwide - Cardiovascular Management Test Market Share (Percent), 2011 - 2012
  • Figure 6-2: Worldwide - Forecast for Cardiovascular Management Test Market Share (Percent), 2013 - 2018
  • Figure 6-3: Worldwide - Diabetes Management Test Market Share (Percent), 2011 - 2012
  • Figure 6-4: Worldwide - Forecast for Diabetes Management Test Market Share (Percent), 2013 - 2018
  • Figure 6-5: Worldwide - Coagulation Test Market Share (Percent), 2011 - 2012
  • Figure 6-6: Worldwide - Forecast for Coagulation Test Market Share (Percent), 2013 - 2018
  • Figure 6-7: Worldwide - Cancer Management Test Market Share (Percent), 2011 - 2012
  • Figure 6-8: Worldwide - Forecast for Cancer Management Test Market Share (Percent), 2013 - 2018
  • Figure 6-9: Worldwide - Infectious Diseases Test Market Share (Percent), 2011 - 2012
  • Figure 6-10: Worldwide - Forecast for Infectious Diseases Test Market Share (Percent), 2013 - 2018
  • Figure 7-1: Worldwide - Cardiovascular Management Test Market (Million US$), 2011 - 2012
  • Figure 7-2: Worldwide - Forecast for Cardiovascular Management Test Market (Million US$), 2013 - 2018
  • Figure 7-3: Worldwide - Cardiac Marker Immunoassays Market (Million US$), 2011 - 2012
  • Figure 7-4: Worldwide - Forecast for Cardiac Marker Immunoassays Market (Million US$), 2013 - 2018
  • Figure 7-5: Worldwide - Cardiac Risk Markers Market (Million US$), 2011 - 2012
  • Figure 7-6: Worldwide - Forecast for Cardiac Risk Markers Market (Million US$), 2013 - 2018
  • Figure 7-7: Worldwide - Cardiac Markers Molecular Test Market (Million US$), 2011 - 2012
  • Figure 7-8: Worldwide - Forecast for Cardiac Markers Molecular Test Market (Million US$), 2013 - 2018
  • Figure 7-9: Worldwide - Diabetes Management Test Market (Million US$), 2011 - 2012
  • Figure 7-10: Worldwide - Forecast for Diabetes Management Test Market (Million US$), 2013 - 2018
  • Figure 7-11: Worldwide - Blood Glucose Monitoring Market (Million US$), 2011 - 2012
  • Figure 7-12: Worldwide - Forecast for Blood Glucose Monitoring Market (Million US$), 2013 - 2018
  • Figure 7-13: Worldwide - Hemoglobin A1C (HbA1c) Test Market (Million US$), 2011 - 2012
  • Figure 7-14: Worldwide - Forecast for Hemoglobin A1C (HbA1c) Test Market (Million US$), 2013 - 2018
  • Figure 7-15: Worldwide - Coagulation Test Market (Million US$), 2011 - 2012
  • Figure 7-16: Worldwide - Forecast for Coagulation Test Market (Million US$), 2013 - 2018
  • Figure 7-17: Worldwide - Routine Coagulation Test Market (Million US$), 2011 - 2012
  • Figure 7-18: Worldwide - Forecast for Routine Coagulation Test Market (Million US$), 2013 - 2018
  • Figure 7-19: Worldwide - Molecular Coagulation Test Market (Million US$), 2011 - 2012
  • Figure 7-20: Worldwide - Forecast for Molecular Coagulation Test Market (Million US$), 2013 - 2018
  • Figure 7-21: Worldwide - Cancer Management Test Market (Million US$), 2011 - 2012
  • Figure 7-22: Worldwide - Forecast for Cancer Management Test Market (Million US$), 2013 - 2018
  • Figure 7-23: Worldwide - Pharmacognostic Histology Test Market (Million US$), 2011 - 2012
  • Figure 7-24: Worldwide - Forecast for Pharmacognostic Histology Test Market (Million US$), 2013 - 2018
  • Figure 7-25: Worldwide - Flow Cytometry Market (Million US$), 2011 - 2012
  • Figure 7-26: Worldwide - Forecast for Flow Cytometry Market (Million US$), 2013 - 2018
  • Figure 7-27: Worldwide - Tumor Markers Market (Million US$), 2011 - 2012
  • Figure 7-28: Worldwide - Forecast for Tumor Markers Market (Million US$), 2013 - 2018
  • Figure 7-29: Worldwide - Human Papillomavirus (HPV) Test Market (Million US$), 2011 - 2012
  • Figure 7-30: Worldwide - Forecast for Human Papillomavirus (HPV) Test Market (Million US$), 2013 - 2018
  • Figure 7-31: Worldwide - Molecular Assays Market (Million US$), 2011 - 2012
  • Figure 7-32: Worldwide - Forecast for Molecular Assays Market (Million US$), 2013 - 2018
  • Figure 7-33: Worldwide - Circulating Tumor Cells Market (Million US$), 2011 - 2012
  • Figure 7-34: Worldwide - Forecast for Circulating Tumor Cells Market (Million US$), 2013 - 2018
  • Figure 7-35: Worldwide - Infectious Diseases Test Market (Million US$), 2011 - 2012
  • Figure 7-36: Worldwide - Forecast for Infectious Diseases Test Market (Million US$), 2013 - 2018
  • Figure 7-37: Worldwide - HIV CD4 Count Market (Million US$), 2011 - 2012
  • Figure 7-38: Worldwide - Forecast for HIV CD4 Count Market (Million US$), 2013 - 2018
  • Figure 7-39: Worldwide - HIV Viral Load Test Market (Million US$), 2011 - 2012
  • Figure 7-40: Worldwide - Forecast for HIV Viral Load Test Market (Million US$), 2013 - 2018
  • Figure 7-41: Worldwide - HCV Viral Load Test Market (Million US$), 2011 - 2012
  • Figure 7-42: Worldwide - Forecast for HCV Viral Load Test Market (Million US$), 2013 - 2018
  • Figure 7-43: Worldwide - HBV Viral Load Test Market (Million US$), 2011 - 2012
  • Figure 7-44: Worldwide - Forecast for HBV Viral Load Test Market (Million US$), 2013 - 2018
  • Figure 7-45: Worldwide - HAI Molecular Test Market (Million US$), 2011 - 2012
  • Figure 7-46: Worldwide - Forecast for HAI Molecular Test Market (Million US$), 2013 - 2018
  • Figure 7-47: Worldwide - Sepsis Immunos Test Market (Million US$), 2011 - 2012
  • Figure 7-48: Worldwide - Forecast for Sepsis Immunos Test Market (Million US$), 2013 - 2018
  • Figure 7-49: Worldwide - Multi Drug Resistant Tuberculosis (MDR-TB) Market (Million US$), 2011 - 2012
  • Figure 7-50: Worldwide - Forecast for Multi Drug Resistant Tuberculosis (MDR-TB) Market (Million US$), 2013 - 2018
  • Figure 7-51: Worldwide - Microbiology ID/AST Market (Million US$), 2011 - 2012
  • Figure 7-52: Worldwide - Forecast for Microbiology ID/AST Market (Million US$), 2013 - 2018
  • Figure 7-53: Worldwide - Psychiatric Disorders Test Market (Million US$), 2011 - 2012
  • Figure 7-54: Worldwide - Forecast for Psychiatric Disorders Test Market (Million US$), 2013 - 2018
  • Figure 7-55: Worldwide - Transplant Tissue Typing (HLA) Test Market (Million US$), 2011 - 2012
  • Figure 7-56: Worldwide - Forecast for Transplant Tissue Typing (HLA) Test Market (Million US$), 2013 - 2018
  • Figure 7-57: Worldwide - Molecular Blood Typing Market (Million US$), 2011 - 2012
  • Figure 7-58: Worldwide - Forecast for Molecular Blood Typing Market (Million US$), 2013 - 2018

List of Tables:

  • Table 3-1: Worldwide - By Diseases Personalized Medicine Diagnostic Market Share (Percent), 2011 - 2012
  • Table 3-2: Worldwide - Forecast for By Diseases Personalized Medicine Diagnostic Market Share (Percent), 2013 - 2018
  • Table 7-1: Selected Human Papillomavirus (HPV) Tests, 2011
  • Table 7-2: Selected Molecular Personalized Medicine Tests in Cancer, 2011
  • Table 8-1: Clinical Trial - Biomarker Research for Personalized Medicine in Blood Cancer Patient
  • Table 8-2: Clinical Trial - Genetic & Environmental Determinants of Immune Phenotype Variance: Establishing a Path Towards Personalized Medicine
  • Table 8-3: Clinical Trial - Warfarin Adverse Event Reduction for Adults Receiving Genetic Testing at Therapy Initiation
  • Table 8-4: Clinical Trial - Genetic Analysis for Personalized Medicine for Morbid Obesity
  • Table 8-5: Clinical Trial - Pharmacogenomics for Antidepressant Guidance & Education
  • Table 8-6: Clinical Trial - I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging & molecular Analysis)
  • Table 8-7: Clinical Trial - Genetic Mechanisms in Human Hypertension RAAS Inhibition Study
  • Table 8-8: Clinical Trial - Open Label Study for the Functional Characterization of Drug Metabolism and Transport
  • Table 8-9: Clinical Trial - Personalized Therapy in Non-small Cell Lung Cancer
  • Table 8-10: Clinical Trial - A Pilot Study of Personalized Medicine for Pediatric Asthma
  • Table 9-1: Key Investors in Personalized Medicine, 2011 & 2012
  • Table 10-1: Partnership & Alliance Models in Personalized Medicine
Back to Top